These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29226171)

  • 21. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.
    Akram M; Shahid M; Khan AU
    Ann Clin Microbiol Antimicrob; 2007 Mar; 6():4. PubMed ID: 17378940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting.
    Musicha P; Feasey NA; Cain AK; Kallonen T; Chaguza C; Peno C; Khonga M; Thompson S; Gray KJ; Mather AE; Heyderman RS; Everett DB; Thomson NR; Msefula CL
    J Antimicrob Chemother; 2017 Jun; 72(6):1602-1609. PubMed ID: 28333330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
    J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial resistance from a one health perspective in Cameroon: a systematic review and meta-analysis.
    Mouiche MMM; Moffo F; Akoachere JTK; Okah-Nnane NH; Mapiefou NP; Ndze VN; Wade A; Djuikwo-Teukeng FF; Toghoua DGT; Zambou HR; Feussom JMK; LeBreton M; Awah-Ndukum J
    BMC Public Health; 2019 Aug; 19(1):1135. PubMed ID: 31426792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-acquired urinary tract infections due to extended-spectrum β -lactamase-producing organisms in United Arab Emirates.
    Ranjan Dash N; Albataineh MT; Alhourani N; Khoudeir AM; Ghanim M; Wasim M; Mahmoud I
    Travel Med Infect Dis; 2018; 22():46-50. PubMed ID: 29409967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, antibiotic sensitivity pattern and genetic analysis of extended spectrum beta lactamase producing Escherichia coli and Klebsiella spp among patients with community acquired urinary tract infection in Galle district, Sri Lanka.
    Priyadharshana U; Piyasiri LB; Wijesinghe C
    Ceylon Med J; 2019 Dec; 64(4):140-145. PubMed ID: 32120467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998-2016): a surveillance study.
    Musicha P; Cornick JE; Bar-Zeev N; French N; Masesa C; Denis B; Kennedy N; Mallewa J; Gordon MA; Msefula CL; Heyderman RS; Everett DB; Feasey NA
    Lancet Infect Dis; 2017 Oct; 17(10):1042-1052. PubMed ID: 28818544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now?
    Kariuki S; Kering K; Wairimu C; Onsare R; Mbae C
    Infect Drug Resist; 2022; 15():3589-3609. PubMed ID: 35837538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone.
    Leski TA; Taitt CR; Bangura U; Stockelman MG; Ansumana R; Cooper WH; Stenger DA; Vora GJ
    BMC Infect Dis; 2016 Apr; 16():167. PubMed ID: 27090787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).
    Cantón R; Loza E; Aznar J; Castillo FJ; Cercenado E; Fraile-Ribot PA; González-Romo F; López-Hontangas JL; Rodríguez-Lozano J; Suárez-Barrenechea AI; Tubau F; Díaz-Regañón J; López-Mendoza D;
    Rev Esp Quimioter; 2019 Apr; 32(2):145-155. PubMed ID: 30761824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial Resistance and Molecular Characterization of Extended-Spectrum β-Lactamases of Escherichia coli and Klebsiella spp. Isolates from Urinary Tract Infections in Southern Brazil.
    Pereira JL; Volcão LM; Klafke GB; Vieira RS; Gonçalves CV; Ramis IB; da Silva PEA; von Groll A
    Microb Drug Resist; 2019 Mar; 25(2):173-181. PubMed ID: 30133334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut mucosal colonisation with extended-spectrum beta-lactamase producing Enterobacteriaceae in sub-Saharan Africa: a systematic review and meta-analysis.
    Lewis JM; Lester R; Garner P; Feasey NA
    Wellcome Open Res; 2019; 4():160. PubMed ID: 31976380
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010.
    Huang CC; Chen YS; Toh HS; Lee YL; Liu YM; Ho CM; Lu PL; Liu CE; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Xu Y; Ni Y; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S4-10. PubMed ID: 22749058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.
    Bi W; Li B; Song J; Hong Y; Zhang X; Liu H; Lu H; Zhou T; Cao J
    Int J Antimicrob Agents; 2017 Jul; 50(1):29-34. PubMed ID: 28456703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
    Zaoutis TE; Goyal M; Chu JH; Coffin SE; Bell LM; Nachamkin I; McGowan KL; Bilker WB; Lautenbach E
    Pediatrics; 2005 Apr; 115(4):942-9. PubMed ID: 15805368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial otitis media in sub-Saharan Africa: a systematic review and meta-analysis.
    Tesfa T; Mitiku H; Sisay M; Weldegebreal F; Ataro Z; Motbaynor B; Marami D; Teklemariam Z
    BMC Infect Dis; 2020 Mar; 20(1):225. PubMed ID: 32183752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae from urinary tract infections: Evolution of antimicrobial resistance and treatment options.
    Jiménez-Guerra G; Heras-Cañas V; Béjar Molina LDC; Sorlózano-Puerto A; Navarro-Marí JM; Gutiérrez-Fernández J
    Med Clin (Barc); 2018 Apr; 150(7):262-265. PubMed ID: 28992981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Extended Spectrum Beta-Lactamase Producing Klebsiella Pneumoniae Isolated From Urinary Tract Infected Patients.
    Chaudhary P; Bhandari D; Thapa K; Thapa P; Shrestha D; Chaudhary HK; Shrestha A; Parajuli H; Gupta BP
    J Nepal Health Res Counc; 2016 May; 14(33):111-115. PubMed ID: 27885293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia.
    Kader AA; Angamuthu K
    Saudi Med J; 2005 Jun; 26(6):956-9. PubMed ID: 15983682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.